The expression of matrix metalloproteinase-11 protein in various types of glomerulonephritis

Nephrology Dialysis Transplantation

Volumn 22, Issue 1, 2007, Pages 109-117

  Nakopoulou, Lydia ^a   Lazaris, Andreas C ^a   Boletis, Ioannis ^b   Michail, Spyros ^b   Iatrou, Christos ^c   Papadakis, Gabriel ^d   Athanassiadou, Sophia ^a   Stathakis, Charalambos ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b KAT HOSPITAL   (Greece)

^c Renal Unit   (Greece)

^d TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

Glomerulonephritis; Immunohistochemistry; Macrophages; Matrix metalloproteinase 11; Microscopic polyangiitis

Indexed keywords

AUTACOID; CD68 ANTIGEN; KI 67 ANTIGEN; NEUTROPHIL CYTOPLASMIC ANTIBODY; STROMELYSIN 3;

ARTICLE; CELL AGGREGATION; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MAJOR CLINICAL STUDY; MESANGIUM; MICROSCOPIC POLYANGIITIS; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL VESSEL VASCULITIS; WEGENER GRANULOMATOSIS;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOPSY; CELL PROLIFERATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLOMERULONEPHRITIS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KI-67 ANTIGEN; KIDNEY DISEASES; LUPUS; MACROPHAGES; MATRIX METALLOPROTEINASE 11;

EID: 33845983282     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl618     Document Type: Article

References (25)

1. Olson JL. Progression of renal disease. In: Jenette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney. Vol. 1, Lippincott-Raven, Philadelphia: 1998; 137-167
2. Rodrigo E, Lopez-Hoyos M, Escallada R et al. Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy. Nephrol Dial Transplant 2000; 15: 2041-2045
3. Akiyama K, Shikata K, Sugimoto H et al. Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis. Res Commun Mol Pathol Pharmacol 1997; 95: 115-128
4. Marti HP. Role of matrix metalloproteinases in the progression of renal lesions. Press Med 2000; 29: 811-817
5. Lelongt B, Legallicier B, Piedagnel R, Ronco PM. Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases? Curr Opin Nephrol Hypertens 2001; 10: 7-12
6. Steinmann-Niggli K, Ziswiler R, Kung M, Marti HP. Inhibition of matrix metalloproteinases attenuates anti-Thy 1.1 nephritis. J Am Soc Nephrol 1998; 9: 397-407
7. Nikolic-Paterson DJ, Atkins RC. The role of macrophages in glomerulonephritis. Nephrol Dial Transplant 2001; 16 [Suppl 5]: 3-7
8. Jenette JC. Renal involvement in systemic vasculitis. In: Jenette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney. Vol. 2, Lippincott-Raven, Philadelphia: 1998; 1059-1096
9. Isbel NM, Nikolic-Paterson DJ, Hill PA, Dowling J, Atkins RC. Local macrophage proliferation correlates with increased renal M-CSF expression in human glomerulonephritis. Nephrol Dial Transplant 2001; 16: 1638-1647
10. Ishizugya-Oka A, Li Q, Amano T et al. Requirement for matrix metalloproteinase stromelysin-3 in cell migration and apoptosis during tissue remodeling in Xenopus laevis. J Cell Biol 2000; 150: 1177-1188
11. Lijnen HR, Van Hoef B, Vanlinthout I et al. Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation. Arterioscler Thromb Vasc Biol 1999; 19: 2863-2870
12. Martin J, Eynstone L, Davies M, Steadman R. Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix. J Am Soc Nephrol 2001; 12: 88-96
13. Kitahara M, Ichikawa M, Kinoshita T et al. Prostacyclin inhibits the production of MMP-9 induced by phorbol ester through protein kinase A activation, but does not affect the production of MMP-2 in human cultured mesangial cells. Kidney Blood Press Res 2001; 24: 18-26
14. Noel A, Boulay A, Kebers F et al. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity. Oncogene 2000; 19: 1605-1612
15. Jennette JC, Thomas DB, Falk RJ. Microscopic polyangiitis (Microscopic polyarteritis). Semin Diagn Pathol 2001; 18: 3-13
16. Kitamura M. Adaptive transfer of nuclear factor-kappa B-inactive macrophages to the glomerulus. Kidney Int 2000; 57: 709-716
17. Shiozawa S. Participation of macrophages in glomerular sclerosis through the expression and activation of matrix metalloproteinases. Pathol Int 2000; 50: 441-457
18. Colvin RB. Renal transplant pathology. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney. Vol. 1, Lippincott-Raven, Philadelphia: 1998; 1409-1540
19. Harendza S, Schneider A, Helmchen U, Stahl RA. Extracellular matrix deposition and cell proliferation in a model of chronic glomerulonephritis in the rat. Nephrol Dial Transplant 1999; 14: 2873-2879
20. Nakopoulou L, Stefanaki K, Boletis J et al. Immunohistochemical study of epidermal growth factor receptor (EGFR) in various types of renal injury. Nephrol Dial Transplant 1994; 9: 764-769
21. Delany AM, Canalis E. The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts. Endocrinology 2001; 142: 1561-1566
22. Diamond JR, Ricardo SD, Klahr S. Mechanisms of interstitial fibrosis in obstructive nephropathy. Semin Nephrol 1998; 18: 594-602
23. Nakopoulou L, Lazaris AC, Boletis IN et al. Evaluation of E-cadherin/ catenin complex in primary and secondary glomerulonephritis. Am J Kidney Dis 2002; 39: 469-474
24. Rastaldi MP, Ferrario F, Crippa A et al. Glomerular monocytemacrophage features in ANCA-positive renal vasculitis and cryoglobulinemic nephritis. J Am Soc Nephrol 2000; 11: 2036-2043
25. Lan HY, Yang N, Nikolic-Paterson DJ et al. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 2000; 57: 499-509